News

The Blood & Tissue Center Foundation, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here

Media is welcome to contact the Corporate Communications Department for more information. We offer:
  • Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent Articles:

 

Event to Raise Funding for Stem Cell Expansion Laboratory for BioBrodge Global Subsidiary GenCure
September 28, 2015

The Red and White Ball, the annual marquee event of The Blood & Tissue Center Foundation, is coming up on Saturday, Oct. 3.

Proceeds from the event will help GenCure establish a stem cell expansion laboratory. GenCure, The Foundation, QualTex Laboratories and the South Texas Blood & Tissue Center are subsidiaries of San Antonio-based BioBridge Global.

The GenCure laboratory is designed to widen the availability of stem cells, which are used as part of therapy for certain cancers. GenCure's stem cells come exclusively from donated umbilical cord blood and adult donors.

September 14, 2015

The U.S. House of Representatives has approved legislation to extend federal programs supporting research and therapy using bone marrow and cord blood.

The bill passed Tuesday authorizes $23 million annually for the National Cord Blood Inventory Program and $30 million per year for the C.W. Bill Young Cell Transportation Program through fiscal year 2020.

Co-sponsored by U.S. Reps. Chris Smith (R-N.J.) and Doris Matsui (D-Calf.), the Stem Cell Therapeutic and Research Reauthorization Act of 2015 continues programs that otherwise would have expired on Sept. 30. It passed on a voice vote after less than 10 minutes of debate.

The measure still must be approved by the Senate.

August 31, 2015

Pairing donors and patients for marrow transplants is difficult enough, given the genetic requirements for a match.

But, as researchers at the University of California San Francisco discovered, it’s even tougher given the nature of surveys.

A team at UCSF recently used a sample of donors from the National Marrow Donor Program to compare different methods of self-identification via survey. A total of 1,752 potential donors were sent questionnaires with multiple measures of identification, as well as a cheek swab for a DNA sample.

The result: No single measure of self-identification best predicted the genetic ancestry identified in the DNA samples. The most accurate survey information came from the geographic origins of the donors’ grandparents, but even then, the data was not perfect.

Executives from BBG, South Texas Blood & Tissue Center, QualTex Laboratories and GenCure Emphasize Cooperation, Teamwork
August 21, 2015

With everything from a singing vice president to a 7-foot-3 blood drop prancing around the grounds, last week was a memorable one at BioBridge Global (BBG).

It was all part of BBG Team Week, which rolled together five days of activities that even included a major blood drive sponsored by two San Antonio television stations.

“BBG Team Week was remarkable in many ways,” said chief executive officer Linda Myers. “It was great to see people and the organization in a whole new light, and a great way for us to engage with people who do lifesaving work every day. It really was a team-building experience.”

GenCure Contributing to Growth of Research into Life-Changing Therapies
July 22, 2015
Umbilical cord blood has so many medical uses, scientists are starting to find them by accident.
 
In a recent case, researchers looking into a disease related to skin grafts identified a part of umbilical cord blood that can lower inflammation and immune disorders caused by those grafts.
 
At the same time, they found those same proteins, called soluble NKG2D ligands, could be used to treat similar conditions that affect the skin, including eczema, rheumatoid arthritis and perhaps even alopecia areata, an autoimmune disorder that causes hair loss.
 
The discovery, reported in the latest edition of the European Journal of Immunology, comes as the United States marks National Cord Blood Awareness Month in July.
 

Pages